NCT06601010View on ClinicalTrials.gov

The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Pancreatic Cancer.

RecruitingOBSERVATIONAL

Enrollment

30

Participants

Timeline

Start Date

September 24, 2024

Primary Completion Date

July 31, 2026

Study Completion Date

August 31, 2027

Conditions

Pancreatic Cancer

Trial Locations (1)

200025

RECRUITING

Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine, Shanghai

All Listed Sponsors

lead

Ruijin Hospital

OTHER